Informed clinical decisions by outfoxing human FOXN1 variants

Area of Science:

• Immunology
• Genetics
• Developmental Biology

Background:

• Thymic epithelial cells (TECs) are crucial for T-cell development, regulated by the transcription factor forkhead box N1 (FOXN1).
• FOXN1 mutations cause nude immunodeficiency syndrome, affecting thymus and skin/nail development.
• Increased identification of FOXN1 variants due to newborn screening and genetic sequencing.

Purpose of the Study:

• To review and categorize the clinical impacts of diverse FOXN1 variants.
• To correlate FOXN1 mutation type and location with protein function and clinical outcomes.
• To provide functional insights into FOXN1 for improved clinical management.

Main Methods:

• Literature review and analysis of clinical data associated with FOXN1 variants.
• Categorization of mutations based on type (biallelic, monoallelic) and location.
• Correlation of genotype with phenotype, including T-cell lymphopenia and thymic aplasia.

Main Results:

• FOXN1 variants exhibit a spectrum of effects, from benign to pathogenic.
• Most identified FOXN1 mutations are currently classified as variants of unknown significance.
• Monoallelic FOXN1 variants can act in a dominant-negative manner, causing transient T-cell lymphopenia.

Conclusions:

• Understanding the functional impact of FOXN1 variants is essential for accurate diagnosis and patient management.
• Categorizing FOXN1 mutations aids in predicting clinical outcomes and guiding treatment decisions.
• This review offers key functional insights into FOXN1, enhancing clinical care for associated disorders.